In a phase 3, double-blind, randomized, controlled trial, 2,539 adults with a body-mass index (BMI) of 30 or greater, or 27 or greater with at least one weight-related complication, were given weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, or 15 mg) or a placebo for 72 weeks
Holistic Primary Care of Delray Beach offers unique, personalized programs making it easier for you to achieve your health goals
Stay hydrated before and after plasma donation, as GLP-1 medications can already reduce your thirst sensation and appetite
Insurance authorization for the switch may require documentation that semaglutide is no longer effective, which means your provider needs to note the plateau or inadequate response in your medical records
Regardless of concentration
GLP-1 RAs improve CV outcomes, as well as secondary outcomes such as progression of renal disease, in patients with established CV disease or chronic kidney disease (CKD)